Oxford BioDynamics (LON:OBD) Shares Up 7.3% – Here’s Why

Oxford BioDynamics Plc (LON:OBD) shares shot up 7.3% during trading on Thursday . The stock traded as high as GBX 0.20 and last traded at GBX 0.19. 201,755 shares changed hands during trading, a decline of 99% from the average session volume of 15,021,203 shares. The stock had previously closed at GBX 0.18.

Oxford BioDynamics Price Performance

The company’s fifty day moving average is GBX 0.20 and its 200 day moving average is GBX 0.24. The firm has a market cap of £7.29 million, a price-to-earnings ratio of -0.21 and a beta of 0.42. The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.